Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]

B. G.M. Durie, S. V. Rajkumar

Research output: Contribution to journalLetter

3 Scopus citations

Fingerprint Dive into the research topics of 'Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]'. Together they form a unique fingerprint.